Search
AI drug developer Absci partners with Oracle and AMD
2 day ago /
Read about 0 minute
Author：小编
On September 11, 2025, AI drug developer Absci announced a partnership with Oracle and AMD, aiming to accelerate the process of drug discovery driven by generative AI. Its drug discovery platform will utilize Oracle's AI infrastructure and AMD's latest hardware.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
